0.00
100.00%
-1.17
Dopo l'orario di chiusura:
1.16
1.16
+
Ocuphire Pharma Inc Azioni (OCUP) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
1.18%
1.711
|
1.691 | 11.94 | 3.674 | 1.749 |
Operating Expenses |
32.29%
9.419
|
7.12 | 5.549 | 9.063 | 7.88 |
Benefits Costs and Expenses |
35.90%
8.817
|
6.488 | 6.36 | 8.635 | 7.54 |
Costs And Expenses |
35.90%
8.817
|
6.488 | 6.36 | 8.635 | 7.54 |
Operating Income/Loss |
41.98%
-7.708
|
-5.429 | 6.386 | -5.389 | -6.131 |
Income/Loss From Continuing Operations Before Tax |
48.13%
-7.106
|
-4.797 | 5.575 | -4.961 | -5.791 |
Income Tax Expense/Benefit |
100.00%
-
|
-0.002 | 0.014 | - | - |
Income/Loss From Continuing Operations After Tax |
48.20%
-7.106
|
-4.795 | 5.561 | -4.961 | -5.791 |
Net Income/Loss
|
48.20%
-7.106
|
-4.795 | 5.561 | -4.961 | -5.791 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
5,088%
24.52
|
0.4726 | 21.45 | 20.96 | 20.94 |
Diluted Average Shares |
5,088%
24.52
|
0.4726 | 22.41 | 20.96 | 20.94 |
Basic Earnings Per Share |
38.10%
-0.29
|
-0.21 | 0.26 | -0.24 | -0.28 |
Diluted Earnings Per Share |
38.10%
-0.29
|
-0.21 | 0.25 | -0.24 | -0.28 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):